Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Versa Vascular appoints Bill Shields as CEO and announces $15 million in expanded Series C funding.
PRIVATEAug 11, 2026•about 4 hours ago
Amount Raised
$15 Million
Round Type
Series C
Description
Versa Vascular has expanded its Series C funding by securing an additional $15 million. The company continues to grow under the leadership of newly appointed CEO Bill Shields. This funding will help propel its ongoing initiatives. Investors are showing increased confidence in the company's vision and strategy.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech